Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

January 31, 2014

Study Completion Date

June 30, 2014

Conditions
Kidney Transplantation
Interventions
DRUG

Tacrolimus

Standard of care

DRUG

CP-690,550

CP-690,550 5 mg BID

DRUG

CP-690,550

CP-690,550 10 mg BID

Trial Locations (27)

10021

Jack J Dreyfus Clinic, New York

10029

Recanati/Miller Transplantation Institute, New York

10065

New York Presbyterian Hospital / Weill Cornell Medical Center, New York

53226

Froedtert Memorial Lutheran Hospital, Milwaukee

Medical College of Wisconsin, Milwaukee

60611

Northwestern Memorial Hospital, Chicago

Northwestern University-Feinberg School of Medicine, Division of Organ Transplantation, Chicago

63110

Washington University School of Medicine, St Louis

75204

Dallas Transplant Institute, Dallas

75246

Annette C & Harold C Simmons Transplant Institute, Dallas

Baylor University Medical Center, Dallas

76104

Baylor All Saints Medical Center, Fort Worth

80045

University of Colorado Health Sciences Center Renal Clinical Trials Office, Aurora

University of Colorado Health Sciences Center, Aurora

90057

Multi Organ Transplant Center, Los Angeles

St. Vincent Medical Center, Los Angeles

Transplant Research Institute, Los Angeles

92123

Balboa Institute of Transplantation, San Diego

California Institute of Renal Research, San Diego

Sharp Memorial Hospital, San Diego

94115

California Pacific Medical Center, San Francisco

94143

University of California, San Francisco, Kidney Transplant Unit, San Francisco

94304

Stanford School of Medicine, Palo Alto

94305

Stanford University Medical Center, Stanford

97210

Legacy Good Samaritan Hospital, Portland

Legacy Transplant Services, Portland

Northwest Renal Clinic, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00263328 - Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient | Biotech Hunter | Biotech Hunter